Thiamylal

CHEMBL440 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
254.4 g/mol
LogP
3.2
Phase
4

Thiamylal is an ultra-short-acting barbiturate anesthetic that acts on GABA-A receptors to potentiate chloride ion influx, producing rapid induction of general anesthesia when administered intravenously. It was used as an induction agent for surgical anesthesia before the widespread adoption of propofol, offering rapid onset and recovery due to rapid redistribution from the brain to peripheral tissues. Its use has largely been replaced by propofol due to the latter's superior pharmacokinetic profile and recovery characteristics.

分子量

254.3500 g/mol

LogP

3.20

TPSA

90.30 Ų

Lipinski 五规则

符合

Pharmacokinetics (PK)

Pharmacodynamics (PD)

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O

InChI

InChI=1S/C12H18N2O2S/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17)

Molecular Formula

C12H18N2O2S

HBD / HBA

2 / 3

可旋转键数

5

重原子数

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

Thiamylal is an ultra-short-acting barbiturate anesthetic that acts on GABA-A receptors to potentiate chloride ion influx, producing rapid induction of general anesthesia when administered intravenously. It was used as an induction agent for surgical anesthesia before the widespread adoption of propofol, offering rapid onset and recovery due to rapid redistribution from the brain to peripheral tissues. Its use has largely been replaced by propofol due to the latter's superior pharmacokinetic profile and recovery characteristics.

Yes, Thiamylal is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL440. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3032285. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.